Instil Bio, Inc.
TIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $6 | $0 |
| Gross Profit | $0 | $0 | -$6 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $12 | $40 | $141 | $107 |
| G&A Expenses | $44 | $48 | $62 | $48 |
| SG&A Expenses | $44 | $48 | $62 | $51 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $3 |
| Other Operating Expenses | $17 | $72 | -$3 | -$3 |
| Operating Expenses | $74 | $159 | $200 | $156 |
| Operating Income | -$74 | -$159 | -$206 | -$156 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | $3 | -$19 | -$1 |
| Pre-Tax Income | -$74 | -$156 | -$225 | -$157 |
| Tax Expense | $0 | $0 | -$2 | $0 |
| Net Income | -$74 | -$156 | -$223 | -$157 |
| % Margin | – | – | – | – |
| EPS | -11.39 | -24 | -34.46 | -29.6 |
| % Growth | 52.5% | 30.4% | -16.4% | – |
| EPS Diluted | -11.39 | -24 | -34.46 | -29.6 |
| Weighted Avg Shares Out | 7 | 7 | 6 | 5 |
| Weighted Avg Shares Out Dil | 7 | 7 | 6 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $9 | $4 | $0 |
| Interest Expense | $9 | $5 | $2 | $0 |
| Depreciation & Amortization | $4 | $5 | $6 | $3 |
| EBITDA | -$63 | -$147 | -$217 | -$153 |
| % Margin | – | – | – | – |